Adaptive Biotechnologies Corporation Share Price Today, Forecast Target, Chat & Where To Buy [ADPT]

  • Today's Adaptive Biotechnologies Corporation share price is 17.4 (as of 10:11 04-Jun-2026) which is a change of 1.27 or 8.01% from the last closing price of 17.4.
  • With 217,778 shares traded this gives Adaptive Biotechnologies Corporation a market capitalisation of 2,743,160,918.
  • Adaptive Biotechnologies Corporation's most recent daily high has been 17.37 and daily low 15.96. The Adaptive Biotechnologies Corporation share price 52 week high has been 20.76 and the 52 week low 9.78.
  • Based on the most recent Adaptive Biotechnologies Corporation share price opening of 17.4, the current Adaptive Biotechnologies Corporation EPS (earnings per share) are 0.33 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying Adaptive Biotechnologies Corporation Shares

It currently costs 17.4 to buy one share in Adaptive Biotechnologies Corporation (as of 10:11 04-Jun-2026) which is a change of 1.27 or 8.01% from the last closing price of 15.99. To buy shares in Adaptive Biotechnologies Corporation you will need a stock trading platform like City Index.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Adaptive Biotechnologies Corporation A Good Investment?

The below Adaptive Biotechnologies Corporation share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.

Tell us what you think:

Scroll to Top